A backlog at the Commerce Dept. is reportedly stalling Nvidia's H20 chip licenses

Nvidia's ability to sell its H20 AI chips in China faces continued delays, despite earlier Commerce Department indications, as the department grapples with licensing backlogs and internal turmoil. This operational bottleneck is further complicated by national security experts advocating for outright restrictions on these sales, underscoring persistent U.S.-China tech trade tensions and the uncertain regulatory landscape for advanced AI components.

Analysis

Nvidia's (NVDA) ability to resume sales of its H20 AI chips to China is encountering significant operational and political hurdles, creating material uncertainty for its revenue outlook in the region. Despite an initial indication of approval from the U.S. Secretary of Commerce in July, the company has reportedly not yet received the necessary export licenses. This delay is attributed to a severe backlog within the U.S. Department of Commerce, which is suffering from internal turmoil, staff shortages, and a breakdown in industry communications, according to Reuters. Compounding this bureaucratic inefficiency is mounting pressure from national security experts urging the administration to block the sales of these specific chips entirely. This situation highlights a direct conflict between administrative capacity and strategic policy, leaving Nvidia's China-focused strategy in a precarious state and reflecting the persistent regulatory and geopolitical risks associated with U.S.-China tech trade.

Key Decisions for Investors

• Investors should closely monitor any official communications from the U.S. Department of Commerce regarding the status of Nvidia's H20 license applications, as this is the primary catalyst for resolving the current stock overhang.
• It is prudent to factor in the heightened risk to Nvidia's China-related revenue forecasts, as the combination of administrative delays and political pressure could lead to a prolonged or even permanent restriction on these key chip sales.
• Given the uncertain outcome, portfolio managers should assess their position sizing in NVDA to account for increased volatility and the binary nature of the risk tied to the final licensing decision.